New Anticoagulants for Stroke Prevention in Atrial Fibrillation

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
Christian Ruff, MD, MPH, of Harvard Medical School, gives an overview of the anticoagulants currently available for prevention of stroke in patients with atrial fibrillation.

Related Articles
Adults whose mothers were overweight or obese before pregnancy have a dramatically elevated risk of dying from heart disease or stroke, according to a new study presented at the American Heart Association’s Scientific Sessions 2014.
Andexanet alfa showed promise as an anti-Xa reversal agent in new research presented at the American Heart Association's Scientific Session 2014.
Is moderation the key to all things, including exercise?
The American Heart Association today presented its Research Achievement Award for 2014 to Shaun R. Coughlin, M.D., Ph.D., of the University of California, San Francisco, “for transcendent discoveries of cellular signaling mechanisms that control blood platelet activation and clot formation, findings that have led to a new medical therapy for preventing heart attacks and strokes.”
Latest Issues
$auto_registration$